{
    "Title": "EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica",
    "URL": "https://doi.org/10.1371/journal.pntd.0006854",
    "Published": "November 21, 2018",
    "Subject_Areas": [
        "Macrophages",
        "Amastigotes",
        "Drug therapy",
        "Parasitic diseases",
        "Transcription factors",
        "Cytokines",
        "Leishmania",
        "Toll-like receptors"
    ],
    "Authors": {
        "Rana El Hajj": [
            "Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon"
        ],
        "Hanady Bou Youness": [
            "Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon"
        ],
        "Laurence Lachaud": [
            "Centre Hospitalo-Universitaire, Universit\u00e9 de Montpellier, Montpellier, France"
        ],
        "Patrick Bastien": [
            "Centre Hospitalo-Universitaire, Universit\u00e9 de Montpellier, Montpellier, France"
        ],
        "Carine Masquefa": [
            "Facult\u00e9 de Pharmacie, Universit\u00e9 de Montpellier, Montpellier, France"
        ],
        "Pierre-Antoine Bonnet": [
            "Facult\u00e9 de Pharmacie, Universit\u00e9 de Montpellier, Montpellier, France"
        ],
        "Hiba El Hajj": [
            "Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon"
        ],
        "Ibrahim Khalifeh": [
            "Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon"
        ]
    }
}